Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$839M |
| 2 |
Amazon
AMZN
|
+$810M |
| 3 |
Tesla
TSLA
|
+$644M |
| 4 |
TSMC
TSM
|
+$546M |
| 5 |
Johnson & Johnson
JNJ
|
+$389M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$891M |
| 2 |
Home Depot
HD
|
+$441M |
| 3 |
JPMorgan Chase
JPM
|
+$335M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$317M |
| 5 |
ASML
ASML
|
+$315M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.84% |
| 2 | Technology | 15.57% |
| 3 | Consumer Discretionary | 11.88% |
| 4 | Consumer Staples | 10.09% |
| 5 | Financials | 9.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2526
Root
ROOT
$797M
| $1.01M | ﹤0.01% |
226,040
+40,447
| +22% | +$279K |
|
|
FRBK
2527
DELISTED
Republic First Bancorp Inc
FRBK
| $1.01M | ﹤0.01% |
469,346
+50,600
| +12% | +$134K |
|
2528
FB Financial Corp
FBK
$3.09B
| $1M | ﹤0.01% |
27,800
+7,700
| +38% | +$308K |
|
2529
Vince Holding Corp
VNCE
$80.9M
| $1M | ﹤0.01% |
128,150
-11,800
| -8% | -$89.8K |
|
2530
Nerdy
NRDY
$90.4M
| $1M | ﹤0.01% |
444,485
-530,812
| -54% | -$1.15M |
|
2531
Kiniksa Pharmaceuticals
KNSA
$5.99B
| $999K | ﹤0.01% |
66,700
-55,100
| -45% | -$802K |
|
|
DRRX
2532
DELISTED
DURECT Corp
DRRX
| $998K | ﹤0.01% |
288,486
-56,238
| -16% | -$267K |
|
|
ARGO
2533
DELISTED
Argo Group International Holdings, Ltd.
ARGO
| $997K | ﹤0.01% |
38,565
-55,700
| -59% | -$1.37M |
|
|
AEL
2534
DELISTED
American Equity Investment Life Holding Company
AEL
| $995K | ﹤0.01% |
21,800
-42,600
| -66% | -$1.72M |
|
|
NUVA
2535
DELISTED
NuVasive, Inc.
NUVA
| $994K | ﹤0.01% |
+24,100
| New | +$976K |
|
2536
Colony Bankcorp
CBAN
$473M
| $992K | ﹤0.01% |
78,178
-4,000
| -5% | -$53.9K |
|
|
GBIO
2537
DELISTED
Generation Bio
GBIO
| $990K | ﹤0.01% |
25,200
-3,820
| -13% | -$201K |
|
2538
iShares MSCI Singapore ETF
EWS
$1.17B
| $988K | ﹤0.01% |
52,500
+38,900
| +286% | +$703K |
|
2539
BayCom
BCML
$339M
| $985K | ﹤0.01% |
51,900
-2,900
| -5% | -$54.5K |
|
|
CBL
2540
CBL Properties
CBL
$1.8B
| $981K | ﹤0.01% |
42,500
+2,300
| +6% | +$62K |
|
2541
Euroseas
ESEA
$521M
| $979K | ﹤0.01% |
65,233
-1,843
| -3% | -$29.7K |
|
|
REVG
2542
DELISTED
REV Group
REVG
| $978K | ﹤0.01% |
77,500
+1,200
| +2% | +$15.8K |
|
|
PRO
2543
DELISTED
PROS Holdings
PRO
| $975K | ﹤0.01% |
+40,200
| New | +$986K |
|
2544
Everspin Technologies
MRAM
$460M
| $972K | ﹤0.01% |
174,806
-68,467
| -28% | -$402K |
|
2545
Invesco S&P 500 High Beta ETF
SPHB
$957M
| $972K | ﹤0.01% |
15,600
+3,400
| +28% | +$214K |
|
|
VXRT
2546
DELISTED
Vaxart
VXRT
| $972K | ﹤0.01% |
+1,011,816
| New | +$1.43M |
|
|
KG
2547
Kestrel Group
KG
$61.7M
| $970K | ﹤0.01% |
22,990
-1,615
| -7% | -$68.8K |
|
|
BWIN
2548
Baldwin Insurance Group
BWIN
$3.05B
| $970K | ﹤0.01% |
38,600
-63,000
| -62% | -$1.74M |
|
|
DESP
2549
DELISTED
Despegar.com
DESP
| $969K | ﹤0.01% |
188,949
+61,631
| +48% | +$354K |
|
2550
Helios Technologies
HLIO
$2.69B
| $968K | ﹤0.01% |
17,775
-31,100
| -64% | -$1.68M |
|
Similar funds
Jim Simons's Q4 2022 Portfolio in Review
As of Q4 2022, Jim Simons held 4,601 positions worth $73.1B, up 3.4% from $70.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons's Q4 2022 filing shows 626 new, 1,390 increased, 2,018 reduced and 524 closed positions. Its largest new stake was Johnson & Johnson: 2,254,125 shares worth $398M. The largest sale was Microsoft, an estimated $891M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jim Simons's largest Q4 2022 buy was Johnson & Johnson: 2,254,125 shares worth $398M.
- Jim Simons added most to Apple in Q4 2022, an estimated $839M increase.
- Jim Simons's biggest Q4 2022 reduction was Novo Nordisk, cutting an estimated $317M.
- Jim Simons fully exited Microsoft in Q4 2022, selling an estimated $891M.
- Jim Simons's ten largest holdings make up 11% of its $73.1B portfolio in Q4 2022.
- Jim Simons opened 626 new positions and closed 524 in Q4 2022.
- Jim Simons's portfolio value rose 3.4% quarter-over-quarter to $73.1B.
Based on Renaissance Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.